PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
33769184-0	2021	Xanthone glucoside 2-beta-D-glucopyranosyl-1,3,6,7-tetrahydroxy-9H-xanthen-9-one binds to the ATP-binding pocket of glycogen synthase kinase 3beta and inhibits its activity: implications in prostate cancer and associated cardiovascular disease risk.	xanthone glucoside	0-18	glycogen synthase kinase 3 beta	Homo sapiens	116-146
31366304-1	2020	This study identifies and validates hexokinase type 4 (HK4), an isozyme of hexokinase in the liver and pancreas, as an important target of C2-beta-D-glucopyranosyl-1,3,6,7-tetrahydroxyxanthone (betadGT), a xanthone glucoside suggested to have antidiabetic property.	xanthone glucoside	206-224	glucokinase	Homo sapiens	36-53
31366304-1	2020	This study identifies and validates hexokinase type 4 (HK4), an isozyme of hexokinase in the liver and pancreas, as an important target of C2-beta-D-glucopyranosyl-1,3,6,7-tetrahydroxyxanthone (betadGT), a xanthone glucoside suggested to have antidiabetic property.	xanthone glucoside	206-224	glucokinase	Homo sapiens	55-58
31366304-1	2020	This study identifies and validates hexokinase type 4 (HK4), an isozyme of hexokinase in the liver and pancreas, as an important target of C2-beta-D-glucopyranosyl-1,3,6,7-tetrahydroxyxanthone (betadGT), a xanthone glucoside suggested to have antidiabetic property.	xanthone glucoside	206-224	hexokinase 1	Homo sapiens	36-46